From: Who fails to return within 30 days after being tested positive for HIV/STI in a free testing centre?
Factors | FTR30/n | FTR (%) | Univariate analysis | Multivariate analysis* | ||||
---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |||
Age (years) and previous HIV testing | 0.06 | 0.01 | ||||||
≥ 25 | 16/132 | 12 | 1 | 1 | ||||
< 25 and no previous HIV testing | 1/25 | 4 | 0.30 | 0.04–2.39 | 0.31 | 0.03–2.87 | ||
< 25 and previous HIV testing | 13/57 | 23 | 2.14 | 0.95–4.81 | 3.36 | 1.27–8.84 | ||
Birthplace | 0.80 | – | ||||||
Metropolitan France | 16/120 | 13 | 1 | – | ||||
Sub-Saharan Africa | 8/47 | 17 | 1.33 | 0.53–3.36 | – | – | ||
Overseas France or abroad | 6/47 | 13 | 0.95 | 0.35–2.60 | – | – | ||
Level of education | 0.37 | – | ||||||
High school graduate | 22/170 | 13 | 1 | – | ||||
Not a high school graduate | 8/44 | 18 | 1.49 | 0.62–3.63 | – | – | ||
Health insurance coverage | 0.52 | – | ||||||
Statutory health insurance | 24/172 | 14 | 1 | – | – | |||
State assistance | 2/23 | 9 | 0.59 | 0.13–2.67 | – | – | ||
None | 4/19 | 21 | 1.64 | 0.50–5.37 | – | – | ||
Sexual orientation | 0.08 | – | ||||||
MSM | 5/76 | 7 | 1 | – | ||||
Heterosexual men | 14/77 | 18 | 3.16 | 1.08–0.25 | – | – | ||
Women | 11/61 | 18 | 3.12 | 1.02–9.55 | – | – | ||
Occasional partners | 0.76 | – | ||||||
No | 18/123 | 15 | 1 | – | ||||
Yes | 12/91 | 13 | 0.89 | 0.40–1.95 | – | – | ||
Self-perceived risk of HIV infection** | < 0.01 | 0.04 | ||||||
Equal or greater than other people | 7/100 | 7 | 1 | 1 | ||||
Less than other people or no risk | 23/114 | 20 | 3.35 | 1.37–8.21 | 2.79 | 1.07–7.30 | ||
Consultation for risk-taking | 0.21 | – | ||||||
No | 13/71 | 18 | 1 | – | ||||
Yes | 17/143 | 12 | 0.60 | 0.27–1.32 | – | – | ||
Accompanied by another person | 0.03 | 0.01 | ||||||
No | 19/169 | 11 | 1 | 1 | ||||
Yes | 11/45 | 24 | 2.55 | 1.11–5.86 | 3.45 | 1.36–8.91 | ||
Anonymous testing | 0.10 | – | ||||||
Yes | 15/136 | 11 | 1 | – | ||||
No | 15/78 | 19 | 1.92 | 0.88–4.18 | – | – | ||
Participation in SMS programme | 0.10 | – | ||||||
Yes | 18/155 | 12 | 1 | – | ||||
No | 12/59 | 20 | 1.94 | 0.87–4.33 | – | – | ||
Chlamydia/gonorrhoea testing | 0.02 | < 0.01 | ||||||
Not tested for chlamydia/gonorrhoea | 10/35 | 29 | 1 | 1 | ||||
Chlamydia/gonorrhoea testing with presumptive treatment | 4/19 | 21 | 0.67 | 0.18–2.51 | 0.55 | 0.12–2.56 | ||
Chlamydia/gonorrhoea testing without presumptive treatment | 16/160 | 10 | 0.28 | 0.11–0.68 | 0.21 | 0.07–0.59 |